Nevertheless, little could be retrieved about PAX2's predictive efficacy in HCC and the interplay between miR-122/148a and PAX2 in HCC, which, on the other hand, demonstrated the novelty of this study. The gene discussed is PAX2; the disease is hepatocellular carcinoma.